Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005-2010.

Nam YS, Cho SY, Yang HY, Park KS, Jang JH, Kim YT, Jeong JW, Suh JT, Lee HJ.

Int J Antimicrob Agents. 2013 Feb;41(2):126-9. doi: 10.1016/j.ijantimicag.2012.10.004. Epub 2012 Dec 20.

PMID:
23265914
2.

Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.

Piekarska K, Wołkowicz T, Zacharczuk K, Rzeczkowska M, Chróst A, Bareja E, Olak M, Gierczyński R.

Int J Antimicrob Agents. 2015 Mar;45(3):238-43. doi: 10.1016/j.ijantimicag.2014.09.019. Epub 2014 Nov 13.

PMID:
25468717
3.

Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.

Jeong HS, Kim JA, Shin JH, Chang CL, Jeong J, Cho JH, Kim MN, Kim S, Kim YR, Lee CH, Lee K, Lee MA, Lee WG, Shin JH, Lee JN.

Microb Drug Resist. 2011 Dec;17(4):551-7. doi: 10.1089/mdr.2011.0095. Epub 2011 Aug 10.

PMID:
21830947
4.

Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.

Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, Lee YC, Cho DT, Lee JC.

Int J Antimicrob Agents. 2010 Jan;35(1):76-9. doi: 10.1016/j.ijantimicag.2009.08.003. Epub 2009 Sep 24.

PMID:
19781915
5.

Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.

Kim MS, Jun LJ, Shin SB, Park MA, Jung SH, Kim K, Moon KH, Jeong HD.

J Microbiol Biotechnol. 2010 Dec;20(12):1735-43.

6.

Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.

Bansal S, Tandon V.

Int J Antimicrob Agents. 2011 Mar;37(3):253-5. doi: 10.1016/j.ijantimicag.2010.11.022. Epub 2011 Jan 13.

PMID:
21236644
7.

Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.

Yang J, Luo Y, Cui S, Wang W, Han L.

Microb Drug Resist. 2011 Sep;17(3):363-7. doi: 10.1089/mdr.2011.0034. Epub 2011 May 12.

PMID:
21563956
8.

Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.

Yang H, Duan G, Zhu J, Zhang W, Xi Y, Fan Q.

Int J Antimicrob Agents. 2013 Aug;42(2):173-7. doi: 10.1016/j.ijantimicag.2013.04.026. Epub 2013 Jun 21.

PMID:
23796894
9.

Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital.

Crémet L, Caroff N, Dauvergne S, Reynaud A, Lepelletier D, Corvec S.

Pathol Biol (Paris). 2011 Jun;59(3):151-6. doi: 10.1016/j.patbio.2009.04.003. Epub 2009 May 29.

PMID:
19481883
10.

Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.

Margaritis A, Galani I, Chatzikonstantinou M, Petrikkos G, Souli M.

J Med Microbiol. 2017 Mar;66(3):266-275. doi: 10.1099/jmm.0.000397. Epub 2017 Mar 20.

PMID:
27902429
11.
12.

Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae.

Lindbäck E, Rahman M, Jalal S, Wretlind B.

APMIS. 2002 Sep;110(9):651-7.

PMID:
12529019
13.

Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.

Gu DX, Hu YJ, Zhou HW, Zhang R, Chen GX.

Microb Drug Resist. 2015 Jun;21(3):345-51. doi: 10.1089/mdr.2014.0057. Epub 2014 Dec 16.

PMID:
25514581
14.

Type II topoisomerase mutations in clinical isolates of Enterobacter cloacae and other enterobacterial species harbouring the qnrA gene.

Lascols C, Robert J, Cattoir V, Bébéar C, Cavallo JD, Podglajen I, Ploy MC, Bonnet R, Soussy CJ, Cambau E.

Int J Antimicrob Agents. 2007 Apr;29(4):402-9. Epub 2007 Jan 23.

PMID:
17254753
16.
17.

Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.

Navia MM, Ruiz J, Ribera A, de Anta MT, Vila J.

J Antimicrob Chemother. 1999 Dec;44(6):743-8. Erratum in: J Antimicrob Chemother 2000 Apr;45(4):556.

PMID:
10590274
20.

Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.

Zhou Y, Yu L, Li J, Zhang L, Tong Y, Kan B.

Int J Antimicrob Agents. 2013 Jul;42(1):72-5. doi: 10.1016/j.ijantimicag.2013.03.004. Epub 2013 May 1.

PMID:
23643392

Supplemental Content

Support Center